Share on Facebook
Share on Twitter
Share on LinkedIn

NEW YORK (Reuters) -Boston Scientific Corp agreed to pay $188.7 million to settle claims by most U.S. states that it deceptively marketed its surgical mesh devices to consumers.

The settlement with 47 states and Washington, D.C. was announced on Tuesday by several state attorneys general. Boston Scientific also agreed to describe more accurately to consumers the safety and risks of using mesh.

Johnson & Johnson and its Ethicon unit reached a similar $117 million multistate settlement over the devices in 2019, while Becton Dickinson and Co and its CR Bard unit reached a $60 million accord last September.

Read more here